Filing Flows › Innospec (IOSP) › Q2 2026 › vs Q2 2025
Innospec (IOSP) Q2 2026 vs Q2 2025 (year over year)
Innospec's revenue rose $51.7M (+12%) from $440M in Q2 2025 to $491M in Q2 2026. Gross margin 28.1% against 28.0% (+0.1 pts).
Innospec, Q2 2026: revenue $491M (+12% year over year), operating margin 8.1%, net earnings $31.2M, operating cash flow $7.2M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 28.1% | 28.0% | +0.1 pts |
| Operating margin | 8.1% | 7.8% | +0.3 pts |
| Net margin | 6.3% | 5.4% | +0.9 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $491M | $440M | $51.7M | +12% |
| Gross profit | $138M | $123M | $15.1M | +12% |
| Cost of revenue | $353M | $316M | $36.6M | +12% |
| Other income, net | $1.9M | −$2.0M | $3.9M | — |
| Operating profit | $39.7M | $34.3M | $5.4M | +16% |
| Operating expenses | $98.6M | $88.9M | $9.7M | +11% |
| Pre-tax earnings | $41.6M | $32.3M | $9.3M | +29% |
| Research & development | $14.2M | $13.6M | $600K | +4% |
| SG&A | $84.3M | $74.6M | $9.7M | +13% |
| Net earnings | $31.2M | $23.9M | $7.3M | +31% |
| Income tax | $10.4M | $8.4M | $2.0M | +24% |
| Operating cash sources | $43.4M | $37.2M | $6.2M | +17% |
| Depreciation & amortization | $10.0M | $11.1M | −$1.1M | -10% |
| Share-based compensation | $2.2M | $2.2M | $0 | 0% |
| Working capital & other | $36.2M | $26.7M | $9.5M | +36% |
| Operating cash flow | $7.2M | $10.5M | −$3.3M | -31% |
| Capital expenditures | $17.7M | $13.0M | $4.7M | +36% |
| Negative free cash flow (OCF − capex) | $10.5M | $2.5M | $8.0M | +320% |
Questions
How much did Innospec's revenue grow year over year in Q2 2026?
Innospec's revenue rose $51.7M (+12%) from $440M in Q2 2025 to $491M in Q2 2026. Gross margin 28.1% against 28.0% (+0.1 pts).